Brownie's Marine Group, Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Brownie's Marine Group, Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.52M | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | $8.17M | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | $7.58M | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | $8.58M | May 9, 2024 |
| FY2022 | Dec 31, 2021 | $6.23M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $4.56M | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | $2.97M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.54M | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | $2.03M | Jun 7, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.52M | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | $8.17M | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | $7.58M | Jun 16, 2025 |
| FY2022 | Dec 31, 2022 | $7.60M | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $5.11M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $3.72M | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | $2.30M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.84M | Jun 29, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.03M | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $2.26M | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $2.76M | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $2.74M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $2.87M | Mar 30, 2015 |
| FY2013 | Dec 31, 2012 | $2.86M | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | $2.21M | Mar 29, 2013 |
| FY2011 | Dec 31, 2010 | $2.18M | Mar 30, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.81M | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | $3.30M | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | $2.11M | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | $2.79M | May 9, 2024 |
| FY2022 | Dec 31, 2021 | $1.89M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $1.46M | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | $448.4K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $315.6K | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | $605.2K | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | $599.5K | Apr 17, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($105.1K) | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | ($240.6K) | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | ($1.25M) | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | ($1.89M) | May 9, 2024 |
| FY2022 | Dec 31, 2021 | ($1.59M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($1.35M) | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | ($1.42M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($1.30M) | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | ($248.7K) | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | $230.0K | Apr 17, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($147.3K) | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | ($146.7K) | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | ($1.17M) | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | ($1.85M) | May 9, 2024 |
| FY2022 | Dec 31, 2021 | ($1.85M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($1.33M) | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | ($1.28M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($1.01M) | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | ($215.1K) | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | ($17.8K) | Apr 17, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.6K | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | $10.0K | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | $13.9K | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | $18.4K | May 9, 2024 |
| FY2022 | Dec 31, 2021 | $75.4K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $115.2K | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | $67.2K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $113.9K | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | $16.4K | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | $2.0K | Apr 17, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.96M | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | $3.44M | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | $3.26M | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | $4.63M | May 9, 2024 |
| FY2022 | Dec 31, 2021 | $3.67M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $2.68M | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.66M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.21M | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | $803.9K | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | $615.3K | Apr 17, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($170.6K) | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | ($293.4K) | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | ($374.8K) | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | ($678.4K) | May 9, 2024 |
| FY2022 | Dec 31, 2021 | ($769.5K) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($556.1K) | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | ($509.6K) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($89.3K) | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | ($326.8K) | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | $75.2K | Apr 17, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $22 | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | $30.0K | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | $11.0K | May 9, 2024 |
| FY2022 | Dec 31, 2021 | $23.7K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $5.5K | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | $96.7K | Mar 31, 2021 |
| FY2018 | Dec 31, 2018 | $12.8K | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | $7.6K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $12.2K | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $82.5K | Mar 30, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.22M | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | $5.77M | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | $4.78M | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | $5.67M | May 9, 2024 |
| FY2022 | Dec 31, 2021 | $4.67M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $2.07M | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.67M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $996.0K | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | $1.32M | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | $1.08M | Apr 17, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.29M | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | $4.19M | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | $3.18M | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | $3.14M | May 9, 2024 |
| FY2022 | Dec 31, 2021 | $2.05M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $1.49M | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | $1.91M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $948.6K | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | $1.02M | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | $914.9K | Apr 17, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.93M | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.58M | Apr 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.59M | Apr 10, 2026 |
| FY2024 | Dec 31, 2022 | $2.52M | Jun 16, 2025 |
| FY2023 | Dec 31, 2021 | $2.63M | May 9, 2024 |
| FY2022 | Dec 31, 2020 | $583.8K | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | ($243.4K) | Apr 22, 2022 |
| FY2020 | Dec 31, 2018 | $47.4K | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $300.7K | Jun 29, 2020 |
| FY2018 | Dec 31, 2016 | $169.1K | Jun 7, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $250.0K | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | $250.0K | Apr 10, 2026 |
| FY2025 | Dec 31, 2023 | $250.0K | Apr 10, 2026 |
| FY2024 | Dec 31, 2022 | $250.0K | Jun 16, 2025 |
| FY2023 | Dec 31, 2021 | $250.0K | May 9, 2024 |
| FY2022 | Sep 3, 2021 | $250.0K | Mar 30, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.03M) | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | ($17.93M) | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | ($17.69M) | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | ($16.44M) | May 9, 2024 |
| FY2022 | Dec 31, 2021 | ($14.54M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($12.96M) | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | ($11.60M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($10.18M) | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | ($8.88M) | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | ($8.63M) | Apr 17, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $431.1K | May 9, 2024 |
| FY2023 | Dec 31, 2022 | $484.4K | May 9, 2024 |
| FY2022 | Dec 31, 2021 | $643.1K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $345.2K | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | $70.6K | Mar 31, 2021 |
| FY2015 | Dec 31, 2015 | $141.8K | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | $19.2K | Mar 30, 2016 |
| FY2015 | Dec 31, 2013 | $70.1K | Mar 30, 2016 |
| FY2014 | Dec 31, 2012 | $69.3K | Mar 30, 2015 |
| FY2013 | Dec 31, 2011 | $27.2K | Mar 17, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $46.7K | Apr 10, 2026 |
| FY2024 | Dec 31, 2024 | $117.1K | Jun 16, 2025 |
| FY2023 | Dec 31, 2023 | $140.0K | May 9, 2024 |
| FY2022 | Dec 31, 2022 | $210.4K | Mar 30, 2023 |
| FY2020 | Dec 31, 2020 | $60.1K | Mar 31, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | 0 | May 9, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2018 | Dec 31, 2018 | 0 | Jun 7, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 17, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | 0 | May 9, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2018 | Dec 31, 2018 | 0 | Jun 7, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 17, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 503.27M | Apr 10, 2026 |
| FY2025 | Dec 31, 2024 | 449.43M | Apr 10, 2026 |
| FY2024 | Dec 31, 2023 | 437.74M | Jun 16, 2025 |
| FY2023 | Dec 31, 2022 | 425.52M | May 9, 2024 |
| FY2022 | Dec 31, 2021 | 393.85M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 306.19M | Apr 22, 2022 |
| FY2020 | Dec 31, 2019 | 225.54M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 161.09M | Jun 29, 2020 |
| FY2018 | Dec 31, 2017 | 98.19M | Jun 7, 2019 |
| FY2017 | Dec 31, 2016 | 68.91M | Apr 17, 2018 |